Search for Clinical Trial Results
Adenoviridae Infections - 213 Studies Found
Status | Study |
Not yet recruiting |
Study Name: Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma Condition: Locally Advanced or Metastatic Melanoma Date: 2013-05-22 Interventions: Biological: ICOVIR-5 |
Completed |
Study Name: Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine. Condition: Influenza A Subtype H5N1 Infection Date: 2008-09-17 Interventions:
|
Recruiting |
Study Name: Virus-specific ImmunoTherapy Following Allogeneic Stem Cell Transplantation Condition:
Date: 2016-03-01 Interventions: Biological: virus-specific T-Cells infusion |
Terminated |
Study Name: A Study of Immunotherapy With TIL (Tumor Infiltrating Lymphocytes) in Combination With Intra-tumoral Injections of Interferon Gamma-adenovirus (Ad-IFNg) in Patients With Stage IIIc or Stage IV Metastatic Melanoma (AJCC)(Protocol TIL-Ad-INFg) Condition: Metastatic Melanoma Date: 2010-03-08 Interventions: Other: TIL-Ad-INFg After verification of inclusion and non-inclusion criteria and after obtaining inform |
Recruiting |
Study Name: Clinical Trial of Recombinant Adenovirus Type 5 AIDS Vaccine Condition: Acquired Immunodeficiency Syndrome Date: 2016-05-02 Interventions:
|
Recruiting |
Study Name: Oncolytic Adenovirus-Mediated Gene Therapy for Lung Cancer Condition: Non-small Cell Lung Cancer Stage I Date: 2017-01-19 Interventions: Biological: Ad5-yCD/mutTKSR39rep-ADP Adenovirus oncolytic adenovirus |
Completed |
Study Name: Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent Glioblastoma Condition:
Date: 2012-04-19 Interventions: Biological: delta-24-RGD adenovirus slow continuous microinfusion in and around the brain tumor during 4 |
Active, not recruiting |
Study Name: TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma Condition: Hepatocellular Carcinoma Date: 2013-02-16 Interventions:
|
Recruiting |
Study Name: Cytotoxic T Cells to Prevent Virus Infections Condition:
|
Recruiting |
Study Name: Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors Condition: Head and Neck Neoplasms Date: 2014-10-15 Interventions:
|